Global Blood Plasma Market - Analysis By Type

(Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma

Derived), By Region, By Country (2018 Edition): Opportunities
and Forecast (2013-2023)

• By Type (Immunoglobulins, Albumin,

Factor VIII and Others)
• By Region- North America, Europe, APAC,
RoW.
• By Country - U.S, Canada, Germany,
France, Italy, China, Japan, India,
Australia and South-East Asia.

October 2018
 Table of Content

S.No Particulars Page No.

1. Research Methodology 13

2. Executive Summary 14

3. Strategic Recommendation 16

3.1 Monitoring Blood Supply 17

3.2 Focus on Encouraging more Eligible Donators 18

3.3 Removal Of Restrictions 19

3.4 Proper Screening Of Blood For Diseases 20

4. Global Blood Plasma Market: Product Outlook 21

5. Global Blood Plasma Market: Growth and Forecast 31

5.1 By Value (2013-2017) 32

5.2 By Value (2018-2023) 49

5.3 By Company Share (2017) 50

2
 Table of Content

S.No Particulars Page No.

6. Global Blood Plasma Market Size, By Type: Breakdown (%) 51

6.1 Global Immunoglobulins (IV+SC) Market 54

6.1.1 By Value (2013-2023) 55

6.1.2 By Volume (2013-2023) 56

6.1.3 By Company Share, 2017 57

6.2 Global Albumin Market 58

6.2.1 By Value (2013-2023) 59

6.2.2 By Volume (2013-2023) 60

6.2.3 By Company Share, 2017 61

6.3 Global FVIII (pd) Market 62

6.3.1 By Value (2013-2023) 63

6.3.2 By Volume (2013-2023) 64

6.3.3 By Company Share, 2017 65

3
 Table of Content

S.No Particulars Page No.

6.4 Global Other Plasma Product Market: By Value (2013-2023) 66

6.5 Global Blood Plasma Market: Market Comparison, By Segments 67

6.46 Global Blood Plasma Market: Market Attractiveness, By Segments 68

7. Global Blood Plasma Market Size, By Region: Breakdown (%) 69

7.1 North America Blood Plasma Market 71

7.1.1 By Value (2013-2017) 72

7.1.2 By Value (2018-2023) 75

7.2 Europe Blood Plasma Market 76

7.2.1 By Value (2013-2017) 77

7.2.2 By Value (2018-2023) 80

7.3 APAC Blood Plasma Market 81

7.3.1 By Value (2013-2017) 82

7.3.2 By Value (2018-2023) 85

4
 Table of Content

S.No Particulars Page No.

7.4 ROW Blood Plasma Market 86

7.3.1 By Value (2013-2017) 87

6.1.1 By Value (2013-2023) 92

7.5 Global Blood Plasma Market: Market Comparison, By Regions 93

7.6 Global Blood Plasma Market: Market Attractiveness, By Regions 94

8. Global Blood Plasma Market Dynamics 95

8.1 Drivers 96

8.2 Challanges 102

8.3 Trends 106

9. Blood Plasma Market: Policy and Regulatory Landscape 112

10. Global Blood Plasma Market: Supply Chain Analysis 138

11. Porter Five Forces Analysis 142

5
 Table of Content

S.No Particulars Page No.

12.0 Company Profiles 144

12.1 CSL Limited 145

12.2 Baxter International 147

12.3 Grifols S.A. 149

12.4 Octa Pharma 151

12.5 Emergent Bio-solutions 153

12.6 Antaris Pharma 155

12.7 AMAG Pharma 157

12.8 Kedrion Biota Pharma 159

12.9 Bio delivery Science International 161

12.10 Biotest A.G. 163

6
 List of Figures
Figure No. Figure Title Page No.

Figure 1: Plasma Proteins and Diseases They Treat 29

Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion) 32
Figure 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population) 34
Figure 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016 34
Figure 5: United States Blood Plasma Collection, 2013-2016, in Million Liters 35
Figure 6: Number of Blood Collection Centers in United States, 2013-2016 36
Figure 7: United States Healthcare Expenditure, 2013-2016 36
Figure 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram) 37
Figure 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion) 37
Figure 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram) 38
Figure 11: Worldwide Demand for factor VIII, By Volume (in IU) 39
Figure 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016 40

Figure 13: Number of People With Hemophilia, Worldwide, By Type, 2016 40

Figure 14: Usage of Factor VIII (IU Per Capita)*, 2016 41

Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016 41

Figure 16: Number of People With Hemophilia, By Top 5 Countries, 2016 42

Figure 17: Number of Plasma Fractionation Plants, 2014 43

Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters) 43

Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands) 44

Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of 44

Population)

7
 List of Figures
Figure No. Figure Title Page No.

Figure 21: Global Aged Population (Above 65), 2013-2017 (% of total) 45

Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total) 46
Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) 46
Figure 24: Global Expected Healthcare Industry Outlook 47
Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020 47
Figure 26: Key Factors Driving Global Healthcare Industry 48
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion) 49
Figure 28: Global Blood Plasma Market Share, By Company, 2017 50
Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%) 52
Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%) 53
Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion) 55

Figure 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion) 55

Figure 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons) 56
Figure 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons) 56
Figure 35: Global IVIG Market Share, By Company, 2017 57
Figure 36: Global Albumin Market, By Value, 2013-2017 (USD Billion) 59

Figure 37: Global Albumin Market, By Value, 2018-2023 (USD Billion) 59

Figure 38: Global Albumin Market, By Volume, 2013-2017 (Tons) 60

Figure 39: Global Albumin Market, By Volume, 2018- 2023 (Tons) 60
Figure 40: Global Albumin Market Share, By Company, 2017 61

8
 List of Figures
Figure Figure Title Page No.
No.

Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion) 63

Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion) 63

Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units) 64

Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units) 64

Figure 45: Global FVIII (Pd) Market Share, By Company, 2017 65

Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion) 66

Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion) 66

Figure 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion) 67

Figure 49: Global Market Attractiveness, By Segments, 2023F 68

Figure 50: Healthcare Industry Landscape, By Selected Region 70

Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion) 72

Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD) 73

Figure 53: North America population aged 65 and above, 2013-2017 (% of total) 73

Figure 54: United States health care expenditure per capita,2013-2016(USD) 74

Figure 55: Canada health care expenditure per capita,2013-2016(USD) 74

Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion) 75

Figure 57: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion) 77

Figure 58: Health Expenditure, By Select Country, 2016 (% of GDP) 78

Figure 59: Europe Population ages 65 years and above (% of total population), 2013-17 78

Figure 60: European Country Population Aged 65 and Above, 2012-2017 (% of Total) 79

9
 List of Figures
Figure No. Figure Title Page No.

Figure 61: GDP, Europe Region, By Select Country, 2017 (In Trillion USD) 79

Figure 62: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion) 80

Figure 63: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion) 82

Figure 64: GDP Per Capita in APAC, By Selected Country, 2013 (In USD) 83

Figure 65: GDP Per Capita in APAC, By Select Country, 2016 (In USD) 83

Figure 66: Population ages 65 and above, By Select Country, 2017 (% of total) 84

Figure 67: Population ages 65 and above, By Select Country, 2050 (% of total) 84

Figure 68: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion) 85

Figure 69: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion) 87

Figure 70: GDP Per Capita in ROW, By Select Country, 2013 (In USD) 88

Figure 71: GDP Per Capita in ROW, By Select Country, 2017 (In USD) 88

Figure 72: GDP Per Capita in ROW, By Select Country, 2017 (In USD) 89

Figure 73: Population ages 60 or above, By Select Country, 2050 (% of total) 89

Figure 74: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total) 90

Figure 75: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %) 90

Figure 76: Middle East and North Africa, Population ages 65 and above (% of total) 91

Figure 77: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion) 91

Figure 78: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion) 92

Figure 79: Regional Market Comparison Chart, 2013-2023 (USD Billion) 93

Figure 80: Global Market Attractiveness, By Region, 2023F 94

10
 List of Figure
Figure No. Figure Title Page No.

Figure 81: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) 98
Figure 82: Global Aged Population(Above 65), (% of total) 99

Figure 83: Male population, 2013-2017 (In Billion) 100

Figure 84: Number of People With Dementia (In Million) 101
Figure 85: Grifols Plasma Fractionation Capacity Growth (In Million Litters) 109

Figure 86: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 146
Figure 87: CSL Limited, Sales, By Business Segments, 2017 (In %) 146
Figure 88: CSL Limited, By Geographic Region, 2017 (In %) 146
Figure 89: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 148
Figure 90: Baxter International, By Business Segments, 2017 (In %) 148
Figure 91: Baxter International, By Geographic Region, 2017 (In %) 148
Figure 92: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 150
Figure 93: Grifols S.A, By Business Segments, 2017 (In %) 150
Figure 94: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 152
Figure 95: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 154
Figure 96: Emergent Bio-Solutions , By Geography, 2017 (In %) 154
Figure 97: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 156
Figure 98: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 158
Figure 99: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion) 160
Figure 100: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%) 160

11
 List of Figure
Figure No. Figure Title Page No.

Figure 101: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 162

Figure 102: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) 164

Figure 103: Biotest A.G, By Geography, 2017 (In %) 164

12
 Research Methodology

For our study on Blood Plasma market, we have conducted comprehensive secondary research followed by
an extensive primary research. In the process of secondary research, we have scrutinized industry
documents, accessed from open sources, premium paid databases and our internal knowledge base. In the
process of primary research, we have interviewed various industry experts across the value chain of the
Blood Plasma.

Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the
industry in the last five years, and confirming the findings through primary research. Annual reports of
the companies are scanned to further validate the market size and to estimate the size of various
segments. Market sizing and growth in the forecast period (2018-2023) is estimated through revenue
mapping, growth of Blood Plasma and historical growth pattern of the industry. All the relevant data
points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: Global Blood Plasma Market

By Type - Immunoglobulins (IVIG+SCIG), Albumin, Factor VIII (Plasma Derived))

By Region- North America, Europe, APAC, RoW.

13
 Global Blood Plasma Market
Rapid increase in the plasma derived treatment procedures has been driving the market
of blood plasma globally.

Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)

CAGR: 2013-2017
xx%

2013 2014 2015 2016 2017

Xx Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

14
 Global Blood Plasma Market
New plasma protein products coupled with rapidly surging demand from emerging economies are
expected to support the market growth in forecasted period.

Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)

CAGR: 2018-2023
xx%

2018 2019 2020 2021 2022 2023

Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

15
 Global Blood Plasma Market- By Type
In 2017, Immunoglobulins holds highest share among all the segments owing to its increase in
the usage of other diseases beside primary immune diseases.

Figure 29: Global Blood Plasma Market Size, By Key Drivers

Type, 2017 (%)

xx

xx

IG (IV+SC) Albumin FVIII (Plasmatic) Others

xx

Source: Azoth Analytics Estimates

16
 Global Blood Plasma Market- By Type
In forecast period, IG is expected to create its dominance, while other segments are expected to
capture a major market proportion due to the introduction of new and specialized plasma products.

Figure 30: Global Blood Plasma Market Size, By Key Drivers

Type, 2023F (%)

xx

xx

IG (IV+SC) Albumin FVIII (Plasmatic) Others

xx

Source: Azoth Analytics Estimates

17
 GlobalImmunoglobulins
Global Insulin Pumps (IVIG+SCIG)
Market, By Market
Value
Figure 31: Global Immunoglobulins Market, By Value, 2013- Figure 32: Global Immunoglobulins Market, By Value,
2017 2018-2023(USD Billion)
(USD Billion)
CAGR 2013-2017 CAGR 2018-2023
xx% xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

18
 GlobalImmunoglobulins
Global Insulin Pumps (IVIG+SCIG)
Market, By Market
Value

Figure 33: Global Immunoglobulin Market, By Figure 34: Global Immunoglobulins Market, By
Volume, 2013-2017, Volume (Tons) Volume, 2018-2023(Tons)

CAGR 2013-2017 CAGR 2018-2023

xx% xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

19
Global Immunoglobulins Market: Company Share

Figure 35: Global IVIG Market Share, By Company, 2017

Grifols Shire (Baxter till 2016) CSL Others

20
 North America Blood Plasma Market
Availability of source plasma in abundant quantity has been driving the market of blood plasma in North
America region.

Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)

CAGR: 2013-2017
xx%

2013 2014 2015 2016 2017

Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

21
 North America Blood Plasma Market
Rapidly increasing acceptance of new and specialized blood plasma protein products is expected to back
market growth in the region.

Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)

CAGR: 2018-2023
xx%

2018 2019 2020 2021 2022 2023

Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

22
 Global U.S.A
Insulin Pumps
Blood Market,
Plasma By Value
Market

Figure 57: USA Blood Plasma Market, By Value, 2013- Figure 58: USA Blood Plasma Market, By Value,
2017 (USD Billion) 2018-2023(USD Billion)

CAGR 2013-2017 CAGR 2018-2023

xx% xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

Xx

23
About Azoth Analytics Pvt Ltd.

Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy
services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food &
beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic
market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).

24